Love the stock and the company so got nothing else to do but wait this out. Holding about 20k shares. Short-term PT --- R1 $6.53 R2 $6.72 R3 $7.63-7.67 ... Near-term PT ~ $13.52 ... Long-term PT ~ $40-60 (let's settle on $50).
still not enough revenue generated...will take a while to move this up with fundamentals. I don`t expect anything above 7 till year end.
thelords
⋅
@ulkser, yeah that's a fair point (re: the optics of the low revenue #s) but we'll see how the reimbursements look on the balance sheet in the next few quarters. That being said, it just takes some positive progress on the LDT assays to send it rocketing too
ibhenry740il
⋅
Just waiting for retail and tutes to finally understand how BNGO and #Saphyr #OGM is gonna fully disruptive the cytogenetics industry
Disclosure: holding 22k shares
thelords
⋅
@ibhenry740il, yeah we'll see how people respond when they see the Third Party reimbursements that begin on October 1st... and if they still don't do anything.. then we just gotta wait a few quarters for the revenue to reflect it. (I think it's the optics of 8.4m revenue right now is the "scare" vs ILMN's 3.42B revenue?)